Clinical Trial Update: A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety and early efficacy of KFA115 alone and in combination with pembrolizumab in select advanced cancers; the trial is currently not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Esophagogastric Cancer
• Nasopharyngeal Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Epithelial Cancer
• Renal Cell Carcinoma
• Squamous Cell Carcinoma of Head and Neck
• Thymic Carcinoma

Drugs mentioned

• KFA115
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Carcinoma, Non-Small-Cell Lung, Cutaneous Melanoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING